Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (406)	1/29/2003 11:38:22 PM
From: mopgcw	Read Replies (1) \| Respond to of 598

>>...a 1998 business plan into a 2002 biotech world. It just hasn't worked, from an investment stand. To date. maybe it is wishful thinking, but reminiscing about nbix at $4 -- but I thought that about tlrk @ $20..$10..$6.. How many other companies have been able to pull together a research progress as tlrk -- mlnm? Figure no further partner revenue, they burn year of cash --waste T67 & 607. Still have 4 significant oppty's in T131, T487, merck & lilly projects, plus anything new they come up with and 9-12 months of cash to push them down the pike - what is Cumbre doing as well? It will be a roller-coaster... george